{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:52Z","timestamp":1792839832173,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1053\/j.gastro.2009.07.052","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T09:22:50Z","timestamp":1248945770000},"page":"1661-1668.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"title":["Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1053","volume":"137","author":[{"given":"Loes","family":"van Keimpema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragna","family":"Vanslembrouck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn G.H.","family":"van Oijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin L.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.07.052_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2009.07.052_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2009.07.052_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.med.45.1.23","article-title":"Natural history of autosomal dominant polycystic kidney disease","volume":"45","author":"Fick","year":"1994","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.gastro.2009.07.052_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","author":"Everson","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.07.052_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2009.07.052_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germ-line mutations in PRKCSH are associated with autosomal dominant polycystic liver disease","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2009.07.052_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840110619","article-title":"Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease","volume":"11","author":"Gabow","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.07.052_bib8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.07.052_bib9","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.1840080626","article-title":"Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts","volume":"8","author":"Everson","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.07.052_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1478-3231.2007.01595.x","article-title":"Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease","volume":"28","author":"Hoevenaren","year":"2008","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2009.07.052_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.07.052_bib12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1572-0241.2005.00263.x","article-title":"New advances in evaluation and management of patients with polycystic liver disease","volume":"100","author":"Arnold","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.07.052_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10620-007-0121-x","article-title":"Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts","volume":"53","author":"van Keimpema","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2009.07.052_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11605-007-0376-8","article-title":"Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%","volume":"12","author":"van Keimpema","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.gastro.2009.07.052_bib15","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.07.052_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.1840110406","article-title":"Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin","volume":"11","author":"Everson","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.07.052_bib17","doi-asserted-by":"crossref","first-page":"C1205","DOI":"10.1152\/ajpcell.00313.2002","article-title":"Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes","volume":"284","author":"Gong","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1053\/j.gastro.2009.07.052_bib18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2353\/ajpath.2008.080125","article-title":"Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease","volume":"173","author":"Banales","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2009.07.052_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.07.052_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(00)80377-3","article-title":"Regulation and deregulation of cholangiocyte proliferation","volume":"33","author":"Alvaro","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.07.052_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.07.052_bib22","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/gut.2008.155721","article-title":"Somatostatin analogues reduce liver volume in polycystic liver disease","volume":"57","author":"van Keimpema","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.07.052_bib23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2009.07.052_bib24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s10620-006-9120-6","article-title":"Evaluation of a gastrointestinal symptoms questionnaire","volume":"51","author":"Bovenschen","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2009.07.052_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36)","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1053\/j.gastro.2009.07.052_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0009-9236(99)70011-1","article-title":"Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency","volume":"66","author":"Barbanoj","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.gastro.2009.07.052_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2009.07.052_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2009.07.052_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0091270005277936","article-title":"Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles","volume":"45","author":"Astruc","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2009.07.052_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.07.052_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mce.2007.11.024","article-title":"Somatostatin agonists for treatment of acromegaly","volume":"286","author":"Ben-Shlomo","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1053\/j.gastro.2009.07.052_bib32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2165\/00003495-200868050-00013","article-title":"Lanreotide autogel: a review of its use in the management of acromegaly","volume":"68","author":"Croxtall","year":"2008","journal-title":"Drugs"},{"key":"10.1053\/j.gastro.2009.07.052_bib33","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/jc.2008-0019","article-title":"Gluteal nodules in patients with metastatic midgut carcinoid disease treated with depot somatostatin analogs","volume":"93","author":"Debono","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2009.07.052_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00464-002-9088-z","article-title":"Laparoscopic treatment of simple hepatic cysts and polycystic liver disease","volume":"17","author":"Fiamingo","year":"2003","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2009.07.052_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000658-199703000-00008","article-title":"Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?","volume":"225","author":"Gigot","year":"1997","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2009.07.052_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjsurg.2004.03.011","article-title":"Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease","volume":"189","author":"Konstadoulakis","year":"2005","journal-title":"Am J Surg"},{"key":"10.1053\/j.gastro.2009.07.052_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00464-004-8813-1","article-title":"Laparoscopic palliation of polycystic liver disease","volume":"19","author":"Robinson","year":"2005","journal-title":"Surg Endosc"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509013778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509013778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:36:53Z","timestamp":1762162613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508509013778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0016508509013778"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.07.052","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164712.626518","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.07.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}